Antimicrobial Drugs: Mechanisms, Efficacy, and Resistance

Antimicrobial Drugs

Introduction to Antimicrobial Drugs

Antimicrobial drugs are chemical agents used to treat infections by inhibiting or killing microorganisms. They are a cornerstone of modern medicine, especially in the treatment of bacterial diseases.

• Drugs: Chemical substances used for diagnosis, treatment, or prevention of diseases.

• Chemotherapeutic agents: Agents used to treat diseases by killing or inhibiting the growth of pathogens.

Antimicrobial Agents (Antimicrobials)

• Natural antibiotics: Compounds produced by microorganisms that inhibit or kill other microbes. Example: Penicillin

• Synthetic antimicrobials: Man-made compounds designed to act against microbes. Example: Sulfonamides

• Semi-synthetic antimicrobials: Chemically modified natural antibiotics to improve efficacy or spectrum. Example: Amoxicillin

Bactericidal vs. Bacteriostatic

• Bactericidal: Agents that kill bacteria.

• Bacteriostatic: Agents that inhibit bacterial growth without killing them directly.

Selective Toxicity

Selective toxicity refers to the ability of a drug to target microbial cells without harming host cells. This is more challenging with viruses and fungi due to similarities with host cell structures.

Mechanisms of Action of Antimicrobial Drugs

Inhibition of Cell Wall Synthesis

Many antibiotics target the bacterial cell wall, which is absent in human cells, making this a prime target for selective toxicity.

• Beta-lactams: Inhibit transpeptidase, an enzyme involved in peptidoglycan cross-linking.

  • Penicillins

  • Vancomycin: Binds to D-Ala-D-Ala terminus, blocking cell wall synthesis. Used for resistant bacteria.

  • Bacitracin: Blocks transport of N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) groups.

• Isoniazid: Inhibits mycolic acid synthesis in Mycobacterium species.

Inhibition of Protein Synthesis

These drugs target bacterial ribosomes (70S), which differ from eukaryotic ribosomes (80S).

• Aminoglycosides: Cause distortion/bulging of 30S ribosomal subunit, leading to misreading of mRNA.

  • Example: Streptomycin

• Tetracyclines: Inhibit tRNA entrance into the A site of the ribosome.

  • Example: Tetracycline

• Chloramphenicol: Inhibits peptide bond formation.

• Macrolides/Lincosamides: Block proper movement of ribosome along mRNA, causing 'ribosomal stalling.'

  • Example: Erythromycin

Disruption to Cytoplasmic Membrane

• Example: Polymyxin—disrupts membrane integrity, leading to cell death.

Inhibition of Metabolic Pathways

• Example: Sulfonamide—inhibits folic acid synthesis, which is essential for bacterial growth.

Inhibition of DNA/RNA Synthesis

• Example: Quinolones (e.g., Ciprofloxacin)—inhibit DNA topoisomerase/gyrase activity, preventing DNA replication.

Broad Spectrum vs. Narrow Spectrum Antibiotics

Antibiotics can be classified based on the range of organisms they affect.

• Broad-spectrum antibiotics: Effective against a wide variety of bacteria (both Gram-positive and Gram-negative).

• Narrow-spectrum antibiotics: Target specific types or groups of bacteria.

Broad-spectrum antibiotics are useful for treating mixed infections but may disrupt normal flora and increase the risk of secondary infections.

Routes of Administration

Antibiotics can be administered via different routes, each with its own advantages and disadvantages.

• Oral: Convenient but may be less effective if the drug is poorly absorbed.

• Intravenous (IV): Rapid and complete absorption, used for severe infections.

• Topical: Applied directly to the site of infection, minimizing systemic effects.

Measuring Antibiotic Efficacy

• MIC (Minimum Inhibitory Concentration): The lowest concentration of an antibiotic that inhibits visible growth of a microorganism.

• MBC (Minimum Bactericidal Concentration): The lowest concentration of an antibiotic that kills 99.9% of the original inoculum.

Consequences of Losing Effective Antibiotics

• Treatment of diseases not directly related to infectious disease may become more difficult (e.g., surgeries, cancer therapy, organ transplants).

Antibiotic Resistance

Mechanisms of Resistance

Bacteria can become resistant to antibiotics through several mechanisms, ultimately rendering the drugs ineffective.

• Degrade/deactivate drug: Production of enzymes (e.g., beta-lactamases) that destroy the antibiotic.

• Efflux pumps: Transport proteins that expel antibiotics from the cell.

• Decreased uptake: Alteration of membrane permeability to prevent drug entry.

• Change the structure of the target: Mutations or modifications in the antibiotic's target site.

• Change metabolic pathways: Bypass the metabolic step inhibited by the drug.

• Biofilm formation: Bacteria in biofilms are more resistant due to reduced drug penetration and altered microenvironment.

How Antibiotic Resistance is Acquired

• Overuse/misuse of antibiotics: Inappropriate prescribing or incomplete courses select for resistant strains.

• Genetic mechanisms: Resistance genes can be acquired via mutations or horizontal gene transfer (e.g., R plasmids).

Summary Table: Mechanisms of Action and Examples

Mechanism	Drug Class	Example	Target
Cell wall synthesis inhibition	Beta-lactams	Penicillin	Transpeptidase
Protein synthesis inhibition	Aminoglycosides	Streptomycin	30S ribosomal subunit
Protein synthesis inhibition	Macrolides	Erythromycin	50S ribosomal subunit
Membrane disruption	Polymyxins	Polymyxin B	Cytoplasmic membrane
Metabolic pathway inhibition	Sulfonamides	Sulfanilamide	Folic acid synthesis
DNA synthesis inhibition	Quinolones	Ciprofloxacin	DNA gyrase

Additional info: The notes have been expanded to include definitions, examples, and a summary table for clarity and completeness.